Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome

Documents similaires

• Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants
  par: Alberto De Lorenzo, et autres
  Publié: (2024)
• Guillain‐Barré syndrome: History, pathogenesis, treatment, and future directions
  par: Richard A. C. Hughes
  Publié: (2024)
• Guillain‐Barré syndrome: a comprehensive review
  par: Roberto Bellanti, et autres
  Publié: (2024)
• European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)
  par: Philip Van Damme, et autres
  Publié: (2024)
• European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro‐Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)
  par: Jalesh N. Panicker, et autres
  Publié: (2025)